The effect of novocain and certain new anticholinergic drugs on the course of experimental atherosclerosis.
D001161:Arteriosclerosis; D050197:Atherosclerosis; D018680:Cholinergic Antagonists; D006801:Humans; D010276:Parasympatholytics / Q000494:pharmacology*; D011343:Procaine / Q000494:pharmacology*
D018680:Cholinergic Antagonists; D010276:Parasympatholytics; D011343:Procaine
ARTERIOSCLEROSIS/experimental; PARASYMPATHOLYTICS/pharmacology; PROCAINE/pharmacology